Healthy elderly
Conditions
Interventions
Awa Bancha Autophagy 100 (APGO) Autophagy Habit NMN25000+ (Mikakuto) Fine Autophagy ReCell (Fine) Eating time limit (within 12 hours) Sleep (7 hours or more) Exercise (5 days a week, at least one
Sponsors
AutoPhagyGO Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Healthy adults (male and female) aged 50 to 80 years at the time of consent (without any disease related to the study) (2) Individuals who have received a full explanation of the purpose and content of the study, fully understood the purpose, and voluntarily volunteered to participate and provided written consent to participate in the study.
Exclusion criteria
Exclusion criteria: (1) Individuals who regularly take specified health foods, functional foods, or health foods (including supplements) at least three times a week and are unable to discontinue use of these foods at the time of consent acquisition (e.g., vitamins A, B, C, D, E, DHA/EPA, sesamin, protein, etc.) that may affect the study. (2) Individuals who drink a lot of alcohol. (3) Individuals for whom blood sampling is difficult. (4) Individuals who have difficulty commuting to the examination site. (5) Individuals who are unable to perform the exercises required for the examination due to joint or muscular issues. (6) Individuals with a history or current medical history of serious heart, liver, kidney, or digestive diseases. (7) Individuals with drug or food allergies. (8) Individuals who are currently participating in a clinical study of another drug or health food, or who have completed the study within four weeks of the study's completion, or who plan to participate in another clinical study after agreeing to participate in the current study. (9) Individuals who have donated blood components or 200 mL of whole blood within one month prior to the start of the study. (10) Individuals who have donated 400 mL of whole blood within three months prior to the start of the study. (11) Individuals whose total planned blood collection volume for the study exceeds 1,200 mL when added to the volume of blood collected within 12 months prior to the start of the study. (12) Individuals who are deemed inappropriate for participation in this study by the principal investigator or co-investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive, muscle, and immune function after an 8-week intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Autophagy-related measures; general health checkup parameters; metabolomics, epigenetics, telomere, hormone, and oxidative-stress analyses; sleep and body temperature | — |
Countries
Japan
Contacts
Public ContactMiwako Ishido
AutoPhagyGO Inc. Management Department
Outcome results
None listed